Table 4. FACS analysis of the B cell populations present in the peritoneal cavity three months after competitive bone marrow transplantation.
Donor | 1∶1 | WT:WT | 1∶1 | WT:KO | ||
% cells | gated | CD45.1+ | CD45.2+ | gated | CD45.1+ | CD45.2+ |
FSC-A/SSC-A | 56.2 | 46.4 | 52.4 | 43.1 | 41.5 | 53.5 |
B1 | 11.1 | 50.1 | 48.6 | 9.2 | 63.4** | 34.8** |
CD5+ | 57.2 | 47.3 | 51.3 | 52.4 | 60.9* | 37.5* |
CD5− | 41.4 | 53.2 | 45.9 | 46.2 | 66.1*** | 32.1*** |
B2 | 57.2 | 42.1 | 56.7 | 53.2 | 38.8* | 59.9 |
CD5+ | 16.6 | 38.7 | 58.2 | 13.7 | 38.2 | 58.0 |
CD5− | 81.0 | 42.9 | 56.4 | 83.3 | 39.0* | 60.1 |
Distribution of CD45.1+ and CD45.2+ cells in the peritoneal cavity of recipient mice 3 months after bone marrow transplantation. CD45.1+ WT and CD45.2+ WT or CD45.2+ KO donor cells were mixed at a 1∶1 ratio prior to injection into recipient CD45.1+ mice. The percentage of total cells gated and the percentage of CD45.1+ or CD45.2+ cells for any given gate are shown. Significance was assessed using Student’s t-test and p-values are indicated as *p<0.05, **p<0.01, ***p<0.001.